Please ensure Javascript is enabled for purposes of website accessibility

Health Insurance Premiums Could Rise by Over 40% Due to Coronavirus, Study Warns

By Eric Volkman - Mar 26, 2020 at 5:22PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

U.S. insurers will have to pay tens (or hundreds) of billions of dollars to cover the treatment of COVID-19 patients, and we should expect them to pass those costs along.

A new study indicates that, due to the high medical costs inherent in fighting the COVID-19 coronavirus pandemic, health insurance premiums could rise by as much as 40%-plus over current levels.

The study was conducted by actuaries at Covered California (that state's health insurance marketplace). It attempts to gauge the costs related to various aspects of the coronavirus pandemic, and predict their effect on consumer premiums.

Coronavirus.

Image source: Getty Images

The study predicts that the average patient requiring hospitalized treatment for the disease will incur a bill totaling $72,000 over a 12-day stay. The analysis found that the total resulting costs from treating all those patients at commercial insurance rates could be anywhere from $31 billion to nearly $238 billion.

It's quite possible that a large share of the patients who need to be hospitalized for treatment will be covered by Medicare, as older people are significantly more likely to experience the severest cases of COVID-19. But COVID-19 could wreak havoc on the finances of those who are uninsured or who have health insurance plans with high deductibles.

"Health carriers are in the process of setting rates for 2021," the Covered California analysts wrote. "If carriers must recoup 2020 costs, price for the same level of costs next year, and protect their solvency, 2021 premium increases to individuals and employers from COVID-19 alone could range from 4% to more than 40%."

Insurers across the U.S. are pitching in to battle the coronavirus. CVS Health's (CVS -1.50%) Aetna, for one, is waiving co-pays for COVID-19 diagnostic testing, among other measures. UnitedHealth Group (UNH -2.35%) is making a similar offer regarding diagnostic tests.

On Thursday, both CVS and UnitedHealth outpaced the broader stock market, which rose by about 6%. UnitedHealth did marginally better, advancing nearly 9%, while CVS notched an 8.7% gain. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

UnitedHealth Group Incorporated Stock Quote
UnitedHealth Group Incorporated
UNH
$505.24 (-2.35%) $-12.16
CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$92.53 (-1.50%) $-1.41

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.